Literature DB >> 18372104

Oxidative stress, DNA methylation and carcinogenesis.

Rodrigo Franco1, Onard Schoneveld, Alexandros G Georgakilas, Mihalis I Panayiotidis.   

Abstract

Transformation of a normal cell to a malignant one requires phenotypic changes often associated with each of the initiation, promotion and progression phases of the carcinogenic process. Genes in each of these phases acquire alterations in their transcriptional activity that are associated either with hypermethylation-induced transcriptional repression (in the case of tumor suppressor genes) or hypomethylation-induced activation (in the case of oncogenes). Growing evidence supports a role of ROS-induced generation of oxidative stress in these epigenetic processes and as such we can hypothesize of potential mode(s) of action by which oxidative stress modulates epigenetic regulation of gene expression. This is of outmost importance given that various components of the epigenetic pathway and primarily aberrant DNA methylation patterns are used as potential biomarkers for cancer diagnosis and prognosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372104     DOI: 10.1016/j.canlet.2008.02.026

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  181 in total

1.  Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate.

Authors:  Sachin S Bhusari; Joseph R Dobosy; Vivian Fu; Nima Almassi; Terry Oberley; David F Jarrard
Journal:  Epigenetics       Date:  2010-07-01       Impact factor: 4.528

Review 2.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

Review 3.  Tumor ablation and nanotechnology.

Authors:  Rachel L Manthe; Susan P Foy; Nishanth Krishnamurthy; Blanka Sharma; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

4.  The Subtelomere of Short Telomeres is Hypermethylated in Alzheimer's Disease.

Authors:  Jing-Zhi Guan; Wei-Ping Guan; Toyoki Maeda; Naoki Makino
Journal:  Aging Dis       Date:  2011-12-10       Impact factor: 6.745

5.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

Review 6.  The role of DNA methylation in aging, rejuvenation, and age-related disease.

Authors:  Adiv A Johnson; Kemal Akman; Stuart R G Calimport; Daniel Wuttke; Alexandra Stolzing; João Pedro de Magalhães
Journal:  Rejuvenation Res       Date:  2012-10       Impact factor: 4.663

Review 7.  Blood-borne biomarkers and bioindicators for linking exposure to health effects in environmental health science.

Authors:  M Ariel Geer Wallace; Tzipporah M Kormos; Joachim D Pleil
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2016-10-19       Impact factor: 6.393

Review 8.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 9.  Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence.

Authors:  Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann
Journal:  Antioxid Redox Signal       Date:  2013-04-15       Impact factor: 8.401

10.  Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.

Authors:  Margaret S Lee; Mina Yaar; Mark S Eller; Thomas M Rünger; Ying Gao; Barbara A Gilchrest
Journal:  J Dermatol Sci       Date:  2009-11-10       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.